Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAge Labs (BIOA) Income from Continuing Operations (2023 - 2026)

BioAge Labs' Income from Continuing Operations history spans 2 years, with the latest figure at 25723000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 19.17% to 25723000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 80391000.0, a 13.34% decrease, with the full-year FY2025 number at 80391000.0, down 13.34% from a year prior.
  • Income from Continuing Operations hit 25723000.0 in Q4 2025 for BioAge Labs, down from 20129000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for BIOA hit a ceiling of 12734000.0 in Q1 2024 and a floor of 25723000.0 in Q4 2025.